BUGAMED Biyoteknoloji A.Ş., founded in 2017, is a forward-thinking company headquartered in Turkey, operating at the intersection of Biotechnology, Manufacturing, and Pharmaceutical industries. The company leverages expertise in tissue and materials engineering to transform organic waste into high-tech products, aiming to increase local product diversity and reduce reliance on imported biotechnological materials.
With a mission encapsulated by their slogan, "BUGAMED Biyoteknoloji ile atıklar geleceğe dönüşüyor," the company is committed to addressing significant challenges such as biotechnological raw material shortages and enhancing the value of biomaterials through tissue engineering.
In its latest funding round on 01 June 2023, BUGAMED Biyoteknoloji received a $80.00K seed investment from Alesta Yatırım and TRANGELS. This financial backing underscores investor confidence in BUGAMED's innovative approach to biotechnology and its potential to contribute significantly to the sector.